|
ZNF436 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.096200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.119000E-01 |
| Normal-vs-Stage2 |
9.828100E-04 |
| Normal-vs-Stage3 |
2.196300E-02 |
| Normal-vs-Stage4 |
3.199600E-02 |
| Stage1-vs-Stage2 |
2.983800E-02 |
| Stage1-vs-Stage3 |
2.621000E-01 |
| Stage1-vs-Stage4 |
2.454200E-01 |
| Stage2-vs-Stage3 |
4.167600E-01 |
| Stage2-vs-Stage4 |
7.417400E-01 |
| Stage3-vs-Stage4 |
7.511200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.038100E-02 |
| Normal-vs-AfricanAmerican |
4.987700E-02 |
| Normal-vs-Asian |
3.126800E-01 |
| Caucasian-vs-AfricanAmerican |
9.558600E-01 |
| Caucasian-vs-Asian |
9.470200E-01 |
| AfricanAmerican-vs-Asian |
9.218200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.655600E-03 |
| Normal-vs-Female |
9.550800E-01 |
| Male-vs-Female |
7.527500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.171900E-02 |
| Normal-vs-Extreme_Weight |
1.000170E-01 |
| Normal-vs-Obese |
1.004640E-01 |
| Normal-vs-Extreme_Obese |
8.760600E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.467400E-01 |
| Normal_Weight-vs-Obese |
5.608400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.922600E-01 |
| Extreme_Weight-vs-Obese |
8.299400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.743200E-01 |
| Obese-vs-Extreme_Obese |
2.816200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.201680E-02 |
| Normal-vs-Age(41-60Yrs) |
4.536000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.639400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.018500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.141900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.711200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.137000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.521600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.259490E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.029800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.183100E-03 |
| Normal-VS-Type2 PRCC |
1.149820E-02 |
| Normal-VS-KIRP CIMP |
8.963700E-02 |
| Normal-VS-Unclassified PRCC |
7.217600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.438400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.569000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.961580E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.004600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.581990E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.256800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.425600E-04 |
| Normal-vs-N1 |
4.150300E-02 |
| Normal-vs-N2 |
6.608400E-01 |
| N0-vs-N1 |
4.028800E-01 |
| N0-vs-N2 |
2.762000E-01 |
| N1-vs-N2 |
5.359600E-01 |
|
|
